151 related articles for article (PubMed ID: 2565749)
1. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum.
Oh C; Gardiner TW; Rebec GV
Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749
[TBL] [Abstract][Full Text] [Related]
2. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
Pierce RC; Rebec GV
Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats.
Pierce RC; Rebec GV
Eur J Pharmacol; 1990 Dec; 191(3):295-302. PubMed ID: 1982267
[TBL] [Abstract][Full Text] [Related]
4. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
Ashby CR; Hitzemann R; Rubinstein JE; Wang RY
Brain Res; 1989 Jul; 493(1):194-7. PubMed ID: 2570618
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of acute administration of haloperidol and clozapine on ethanol-induced ascorbic acid release in rat striatum.
Liu W; Wu CF; Liu J; Huang M; Xiao K
Eur J Pharmacol; 2000 Jun; 398(3):333-9. PubMed ID: 10862822
[TBL] [Abstract][Full Text] [Related]
6. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
8. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
Calderon SF; Sanberg PR; Norman AB
Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
[TBL] [Abstract][Full Text] [Related]
9. Concurrent on-line analysis of striatal ascorbate, dopamine and dihydroxyphenylacetic acid concentrations by in vivo voltammetry.
Gonzalez-Mora JL; Sanchez-Bruno JA; Mas M
Neurosci Lett; 1988 Mar; 86(1):61-6. PubMed ID: 3362430
[TBL] [Abstract][Full Text] [Related]
10. A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis.
Yamamoto BK; Pehek EA
Brain Res; 1990 Jan; 506(2):236-42. PubMed ID: 2137360
[TBL] [Abstract][Full Text] [Related]
11. Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: intracellular studies from naive and catecholamine-depleted rats.
Calabresi P; Benedetti M; Mercuri NB; Bernardi G
Neuroscience; 1988 Oct; 27(1):145-57. PubMed ID: 2904663
[TBL] [Abstract][Full Text] [Related]
12. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
Sprah L; Zivin M; Sket D
J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
[TBL] [Abstract][Full Text] [Related]
13. Stimulant-conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning.
Martin-Iverson MT; McManus DJ
Brain Res; 1990 Jun; 521(1-2):175-84. PubMed ID: 2145055
[TBL] [Abstract][Full Text] [Related]
14. Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats.
Pierce RC; Clemens AJ; Shapiro LA; Rebec GV
Psychopharmacology (Berl); 1994 Sep; 116(1):103-9. PubMed ID: 7862921
[TBL] [Abstract][Full Text] [Related]
15. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
Ichikawa J; Meltzer HY
Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
[TBL] [Abstract][Full Text] [Related]
16. Interference by DOPAC and ascorbate during attempts to measure drug-induced changes in neostriatal dopamine with Nafion-coated, carbon-fiber electrodes.
Wiedemann DJ; Basse-Tomusk A; Wilson RL; Rebec GV; Wightman RM
J Neurosci Methods; 1990 Oct; 35(1):9-18. PubMed ID: 2148961
[TBL] [Abstract][Full Text] [Related]
17. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
Brougham LR; Conway PG; Ellis DB
Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649
[TBL] [Abstract][Full Text] [Related]
18. Nonstriatal dopaminergic neurons: Section X. Morphine, amphetamine, and noncataleptogenic neuroleptics: Introduction: morphine, amphetamine, and noncataleptogenic neuroleptics.
Costa E
Adv Biochem Psychopharmacol; 1977; 16():557-63. PubMed ID: 18900
[No Abstract] [Full Text] [Related]
19. Regional selectivity of neuroleptic drugs: an argument for site specificity.
Borison RL; Diamond BI
Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135
[TBL] [Abstract][Full Text] [Related]
20. The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
Plantjé JF; Hansen HA; Daus FJ; Stoof JC
Eur J Pharmacol; 1984 Oct; 105(1-2):73-83. PubMed ID: 6208045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
